TI
IMMU

Trexquant Investment’s Immunomedics Inc IMMU Stock Holding History

Trexquant Investment’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-92,947
Closed -$1.97M – 1571
2019
Q4 		$1.97M Buy
+92,947
New +$1.64M 0.12% 232
2019
Q1 		– Sell
-19,545
Closed -$279K – 1440
2018
Q4 		$279K Sell
19,545
-27,427
-58% -$544K 0.02% 811
2018
Q3 		$978K Buy
46,972
+34,367
+273% +$814K 0.07% 368
2018
Q2 		$298K Buy
+12,605
New +$253K 0.02% 680
2017
Q4 		– Sell
-79,923
Closed -$1.12M – 1336
2017
Q3 		$1.12M Buy
79,923
+50,939
+176% +$508K 0.28% 78
2017
Q2 		$256K Buy
+28,984
New +$204K 0.07% 544

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Trexquant Investment's IMMU Position: Q1 2020 in Review

Trexquant Investment sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 92,947 shares — an estimated $1.97M sold.

Trexquant Investment first reported a position in IMMU in Q2 2017 and held it in 6 quarters. The position peaked at $1.97M in Q4 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • Trexquant Investment reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • Trexquant Investment sold 92,947 Immunomedics Inc shares in Q1 2020, an estimated $1.97M.
  • Trexquant Investment first reported a position in Immunomedics Inc in Q2 2017 and held it in 6 quarters.
  • Trexquant Investment's Immunomedics Inc position peaked at $1.97M in Q4 2019.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Trexquant Investment's 13F filing for Q1 2020, filed 8 May 2020.